PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Centergrid.266813.8, Omaha, Nebraska, USA.\', \'Delhi Pharmaceutical Sciences and Research University, New Delhi, India.\', \'Department of Veterinary Pathobiology, University of Missourigrid.134936.a, Columbia, Missouri, USA.\', \'Bond Life Sciences Center, University of Missourigrid.134936.a, Columbia, Missouri, USA.\', \'Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden.\', \'Department of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Centergrid.266813.8, Omaha, Nebraska, USA.\', \'Department of Biochemistry and Molecular Biology, University of Nebraska Medical Centergrid.266813.8, Omaha, Nebraska, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1128/JVI.01437-21
?:doi
?:hasPublicationType
?:journal
  • Journal of virology
is ?:pmid of
?:pmid
?:pmid
  • 34550770
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.853
?:rankingScore_hIndex
  • 268
is ?:relation_isRelatedTo_publication of
?:title
  • Discovery and Evaluation of Entry Inhibitors for SARS-CoV-2 and Its Emerging Variants.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all